Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
J Neurophysiol ; 126(4): 1172-1189, 2021 10 01.
Artigo em Inglês | MEDLINE | ID: mdl-34469703

RESUMO

Blast-induced hearing difficulties affect thousands of veterans and civilians. The long-term impact of even a mild blast exposure on the central auditory system is hypothesized to contribute to lasting behavioral complaints associated with mild blast traumatic brain injury (bTBI). Although recovery from mild blast has been studied separately over brief or long time windows, few, if any, studies have investigated recovery longitudinally over short-term and longer-term (months) time windows. Specifically, many peripheral measures of auditory function either recover or exhibit subclinical deficits, masking deficits in processing complex, real-world stimuli that may recover differently. Thus, examining the acute time course and pattern of neurophysiological impairment using appropriate stimuli is critical to better understanding and intervening in bTBI-induced auditory system impairments. Here, we compared auditory brainstem response, middle-latency auditory-evoked potentials, and envelope following responses. Stimuli were clicks, tone pips, amplitude-modulated tones in quiet and in noise, and speech-like stimuli (iterated rippled noise pitch contours) in adult male rats subjected to mild blast and sham exposure over the course of 2 mo. We found that blast animals demonstrated drastic threshold increases and auditory transmission deficits immediately after blast exposure, followed by substantial recovery during the window of 7-14 days postblast, although with some deficits remaining even after 2 mo. Challenging conditions and speech-like stimuli can better elucidate mild bTBI-induced auditory deficit during this period. Our results suggest multiphasic recovery and therefore potentially different time windows for treatment, and deficits can be best observed using a small battery of sound stimuli.NEW & NOTEWORTHY Few studies on blast-induced hearing deficits go beyond simple sounds and sparsely track postexposure. Therefore, the recovery arc for potential therapies and real-world listening is poorly understood. Evidence suggested multiple recovery phases over 2 mo postexposure. Hearing thresholds largely recovered within 14 days and partially explained recovery. However, midlatency responses, responses to amplitude modulation in noise, and speech-like pitch sweeps exhibited extended changes, implying persistent central auditory deficits and the importance of subclinical threshold shifts.


Assuntos
Percepção Auditiva/fisiologia , Limiar Auditivo/fisiologia , Traumatismos por Explosões/fisiopatologia , Concussão Encefálica/fisiopatologia , Potenciais Evocados Auditivos/fisiologia , Transtornos da Audição/fisiopatologia , Recuperação de Função Fisiológica/fisiologia , Estimulação Acústica , Animais , Comportamento Animal/fisiologia , Traumatismos por Explosões/complicações , Concussão Encefálica/etiologia , Modelos Animais de Doenças , Eletroencefalografia , Potenciais Evocados Auditivos do Tronco Encefálico/fisiologia , Transtornos da Audição/etiologia , Masculino , Percepção da Altura Sonora/fisiologia , Ratos
2.
Neuron ; 89(4): 725-33, 2016 Feb 17.
Artigo em Inglês | MEDLINE | ID: mdl-26833134

RESUMO

Autism spectrum disorders (ASDs) are a group of devastating neurodevelopmental syndromes that affect up to 1 in 68 children. Despite advances in the identification of ASD risk genes, the mechanisms underlying ASDs remain unknown. Homozygous loss-of-function mutations in Contactin Associated Protein-like 2 (CNTNAP2) are strongly linked to ASDs. Here we investigate the function of Cntnap2 and undertake pharmacological screens to identify phenotypic suppressors. We find that zebrafish cntnap2 mutants display GABAergic deficits, particularly in the forebrain, and sensitivity to drug-induced seizures. High-throughput behavioral profiling identifies nighttime hyperactivity in cntnap2 mutants, while pharmacological testing reveals dysregulation of GABAergic and glutamatergic systems. Finally, we find that estrogen receptor agonists elicit a behavioral fingerprint anti-correlative to that of cntnap2 mutants and show that the phytoestrogen biochanin A specifically reverses the mutant behavioral phenotype. These results identify estrogenic compounds as phenotypic suppressors and illuminate novel pharmacological pathways with relevance to autism.


Assuntos
Transtorno Autístico/tratamento farmacológico , Estrogênios/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Regulação da Expressão Gênica/genética , Proteínas de Membrana/genética , Mutação/genética , Proteínas do Tecido Nervoso/genética , Animais , Animais Geneticamente Modificados , Transtorno Autístico/genética , Modelos Animais de Doenças , Estrogênios/uso terapêutico , Genisteína/farmacologia , Proteínas de Fluorescência Verde/genética , Proteínas de Fluorescência Verde/metabolismo , Humanos , Larva , Proteínas Luminescentes/genética , Proteínas Luminescentes/metabolismo , Atividade Motora/efeitos dos fármacos , Atividade Motora/genética , Fenótipo , Fitoestrógenos/farmacologia , Psicotrópicos/farmacologia , Psicotrópicos/uso terapêutico , Convulsões/tratamento farmacológico , Convulsões/genética , Transtornos da Transição Sono-Vigília/tratamento farmacológico , Transtornos da Transição Sono-Vigília/genética , Proteína Vesicular 2 de Transporte de Glutamato/genética , Proteína Vesicular 2 de Transporte de Glutamato/metabolismo , Peixe-Zebra
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA